These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
418 related items for PubMed ID: 26613265
1. Temperature stability of Poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] in the form of a solution or in the lyophilized form during storage at -80 °C, 4 °C, 25 °C and 37 °C or pasteurization at 70 °C. Bian YZ, Guo C, Chang TM. Artif Cells Nanomed Biotechnol; 2016; 44(1):41-7. PubMed ID: 26613265 [Abstract] [Full Text] [Related]
2. A novel nanobiotherapeutic poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] with no cardiac toxicity for the resuscitation of a rat model with 90 minutes of sustained severe hemorrhagic shock with loss of 2/3 blood volume. Bian Y, Chang TM. Artif Cells Nanomed Biotechnol; 2015 Feb; 43(1):1-9. PubMed ID: 25297052 [Abstract] [Full Text] [Related]
3. Lowering of elevated tissue PCO2 in a hemorrhagic shock rat model after reinfusion of a novel nanobiotechnological polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase that is an oxygen and a carbon dioxide carrier with enhanced antioxidant properties. Bian Y, Wei G, Chang TM. Artif Cells Nanomed Biotechnol; 2013 Feb; 41(1):60-8. PubMed ID: 23347056 [Abstract] [Full Text] [Related]
4. Extraction of superoxide dismutase, catalase, and carbonic anhydrase from stroma-free red blood cell hemolysate for the preparation of the nanobiotechnological complex of polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase. Guo C, Gynn M, Chang TM. Artif Cells Nanomed Biotechnol; 2015 Jun; 43(3):157-62. PubMed ID: 25961364 [Abstract] [Full Text] [Related]
5. Polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase: a novel biotechnology-based blood substitute that transports both oxygen and carbon dioxide and also acts as an antioxidant. Bian Y, Rong Z, Chang TM. Artif Cells Blood Substit Immobil Biotechnol; 2011 Jun; 39(3):127-36. PubMed ID: 21574914 [Abstract] [Full Text] [Related]
6. Long term safety and immunological effects of a nanobiotherapeutic, bovine poly-[hemoglobin-catalase-superoxide dismutase-carbonic anhydrase], after four weekly 5% blood volume top-loading followed by a challenge of 30% exchange transfusion. Guo C, Chang TMS. Artif Cells Nanomed Biotechnol; 2018 Nov; 46(7):1349-1363. PubMed ID: 29873524 [Abstract] [Full Text] [Related]
7. Polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase: a novel biotechnology-based blood substitute that transports both oxygen and carbon dioxide and also acts as an antioxidant. Bian Y, Rong Z, Chang TM. Artif Cells Blood Substit Immobil Biotechnol; 2012 Feb; 40(1-2):28-37. PubMed ID: 21689051 [Abstract] [Full Text] [Related]
8. Preliminary Study on Polymerization between Hemoglobin and Enzymes during the Preparation of PolyHb-SOD-CAT-CA. Zhang L, Tian R, Xiao J, Wang Y, Feng K, Chen G. Dokl Biochem Biophys; 2024 Oct; 518(1):463-474. PubMed ID: 39196524 [Abstract] [Full Text] [Related]
9. Novel Nanodimension artificial red blood cells that act as O2 and CO2 carrier with enhanced antioxidant activity: PLA-PEG nanoencapsulated PolySFHb-superoxide dismutase-catalase-carbonic anhydrase. Gao W, Bian Y, Chang TM. Artif Cells Nanomed Biotechnol; 2013 Aug; 41(4):232-9. PubMed ID: 23336597 [Abstract] [Full Text] [Related]
14. Two future generations of blood substitutes based on polyhemoglobin-SOD-catalase and nanoencapsulation. Chang TM, D'Agnillo F, Yu WP, Razack S. Adv Drug Deliv Rev; 2000 Feb 28; 40(3):213-8. PubMed ID: 10837791 [Abstract] [Full Text] [Related]